Cities Changing Diabetes announces five new programs to fight diabetes and obesity in Philadelphia
Preliminary funding jumpstarts programs designed to address unmet health care needs
News provided by
Share this article
Novo Nordisk, Inc. (PRNewsFoto/Novo Nordisk)
PHILADELPHIA, Jan. 13, 2021 /PRNewswire/ Five innovative community-based programs have been selected to receive preliminary funding to help combat diabetes and obesity in Philadelphia through Cities Changing Diabetes. Cities Changing Diabetes is a global program sponsored by Novo Nordisk, a global healthcare company, that brings together the private and public sectors to find new ways to change the trajectory of diabetes, including reducing obesity which is considered the biggest modifiable risk factor of diabetes, in their neighborhoods and communities. The winning programs were selected by a coalition of local public health, healthcare, faith, academic and community leaders.